AQR Capital Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3K | Buy |
45,706
+22,926
| +101% | +$10.2K | ﹤0.01% | 3283 |
|
|
2025
Q1 | $12.9K | Buy |
+22,780
| New | +$12.9K | ﹤0.01% | 3139 |
|
|
2023
Q4 | – | Sell |
-11,755
| Closed | -$50.5K | – | 2378 |
|
|
2023
Q3 | $50.5K | Buy |
+11,755
| New | +$50.5K | ﹤0.01% | 2283 |
|
|
2022
Q3 | – | Sell |
-34,363
| Closed | -$124K | – | 2250 |
|
|
2022
Q2 | $124K | Sell |
34,363
-190,243
| -85% | -$686K | ﹤0.01% | 2062 |
|
|
2022
Q1 | $1.4M | Sell |
224,606
-132,636
| -37% | -$824K | ﹤0.01% | 1373 |
|
|
2021
Q4 | $2.52M | Buy |
357,242
+43,895
| +14% | +$310K | ﹤0.01% | 1049 |
|
|
2021
Q3 | $2.19M | Buy |
313,347
+288,759
| +1,174% | +$2.02M | ﹤0.01% | 1087 |
|
|
2021
Q2 | $205K | Buy |
+24,588
| New | +$205K | ﹤0.01% | 2137 |
|